Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients

International Journal of Clinical Practice

Volumn 60, Issue 4, 2006, Pages 429-433

  Ersöz, Halil Önder ^a   Ukinc, K ^a   Kose M ^a   Erem, C ^a   Gunduz, A ^a   Hacihasanoglu, A B ^a   Karti, S S ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

hydroxybutyrate; Diabetic ketoacidosis; Insulin lispro; Regular insulin

Indexed keywords

3 HYDROXYBUTYRIC ACID; GLUCOSE; INSULIN; INSULIN LISPRO; KETONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD PH; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

ADULT; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645091884     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2006.00786.x     Document Type: Article

References (17)

1. Fishbein H Palumbo PJ. Diabetes in America (National Diabetes Data Group). Washington DC: National Instutites of Health, In: Harris MI, ed. 1995: 283-91.
2. Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 1983; 117: 551-8.
3. White NH. Diabetic ketoacidosis in children. Endocrinol Metab Clin North Am 2000; 29: 657-82.
4. Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabet Med 1993; 10: 282-4.
5. American Diabetes Association. Hyperglyceamic crisis in patients with diabetes mellitus. Diabetes Care 2003; 26: 109-17.
6. Martin MM, Martin AA. Continuous low-dose infusion of insulin in the treatment of diabetic ketoacidosis in children. J Pediatr 1976; 89: 560-564.
7. Heber D, Molitch ME, Sperling MA. Low-dose continuous insulin therapy for diabetic ketoacidosis. Prospective "comparison with conventional"insulin therapy. Arch Intern Med 1977; 137: 1377-80.
8. 8 Fisher JN, Shahshahani MN, Kitabchi AE. Diabetic ketoacidosis: Low-dose insulin therapy by various routes. N Engl J Med 1977; 297: 238-41.
9. Soler NG, Bennett MA, FitzGerald MG, Malins JM. Intensive care in the management of diabetic ketoacidosis. Lancet 1973; 1: 951-4
10. May ME, Young C, King J. Resource utilization in treatment of diabetic ketoacidosis in adults. Am J Med Sci 1993; 306: 287-94.
11. Freire AX, Umpierrez GE, Afessa B, Latif KA, Bridges L, Kitabchi AE. Predictors of intensive care unit and hospital length of stay in diabetic ketoacidosis. J Crit Care 2002; 17: 207-11.
12. Menzel R, Jutzi E. Blood sugar behavior in recompensation of diabetic coma. Dtsch Gesundheitsw 1970; 25: 727-32.
13. Kitabchi AE, Fisher JN, Burghorn GA, Tsiu H, Huber CT. Problems associated with continuous insulin infusion. Horm Metab Res Suppl 1982; 12: 271-6.
14. Alberti KG, Hockaday TD, Turner RC. Small doses of intramuscular insulin in the treatment of diabetic 'coma'. Lancet 1973; 2: 515-22.
15. Alberti KG. Low-dose insulin in the treatment of diabetic ketoacidosis. Arch Intern Med 1977; 137: 1367-76.
16. Holleman F, Hoekstra JB. Insulin lispro. N Engl J Med 1997; 337: 176-83.
17. Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 2004; 27: 1873-8.